Literature DB >> 31375869

Two of a kind: transmissible Schwann cell cancers in the endangered Tasmanian devil (Sarcophilus harrisii).

Amanda L Patchett1, Tim H H Coorens2, Jocelyn Darby3, Richard Wilson4, Matthew J McKay5, Karthik S Kamath5, Alan Rubin6,7, Matthew Wakefield6,7, Lachlan Mcintosh6,8, Stefano Mangiola6,9, Ruth J Pye3, Andrew S Flies3, Lynn M Corcoran6,7, A Bruce Lyons10, Gregory M Woods3, Elizabeth P Murchison2, Anthony T Papenfuss6,7,11,12, Cesar Tovar3.   

Abstract

Devil facial tumour disease (DFTD) comprises two genetically distinct transmissible cancers (DFT1 and DFT2) endangering the survival of the Tasmanian devil (Sarcophilus harrisii) in the wild. DFT1 first arose from a cell of the Schwann cell lineage; however, the tissue-of-origin of the recently discovered DFT2 cancer is unknown. In this study, we compared the transcriptome and proteome of DFT2 tumours to DFT1 and normal Tasmanian devil tissues to determine the tissue-of-origin of the DFT2 cancer. Our findings demonstrate that DFT2 expresses a range of Schwann cell markers and exhibits expression patterns consistent with a similar origin to the DFT1 cancer. Furthermore, DFT2 cells express genes associated with the repair response to peripheral nerve damage. These findings suggest that devils may be predisposed to transmissible cancers of Schwann cell origin. The combined effect of factors such as frequent nerve damage from biting, Schwann cell plasticity and low genetic diversity may allow these cancers to develop on rare occasions. The emergence of two independent transmissible cancers from the same tissue in the Tasmanian devil presents an unprecedented opportunity to gain insight into cancer development, evolution and immune evasion in mammalian species.

Entities:  

Keywords:  Contagious cancer; DFT2; Devil facial tumour disease; Schwann cell; Tasmanian devil; Transmissible cancer

Mesh:

Substances:

Year:  2019        PMID: 31375869     DOI: 10.1007/s00018-019-03259-2

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  11 in total

1.  Extracellular vesicle proteomes of two transmissible cancers of Tasmanian devils reveal tenascin-C as a serum-based differential diagnostic biomarker.

Authors:  Camila Espejo; Richard Wilson; Eduard Willms; Manuel Ruiz-Aravena; Ruth J Pye; Menna E Jones; Andrew F Hill; Gregory M Woods; A Bruce Lyons
Journal:  Cell Mol Life Sci       Date:  2021-10-16       Impact factor: 9.261

2.  Class II transactivator induces expression of MHC-I and MHC-II in transmissible Tasmanian devil facial tumours.

Authors:  Chrissie E B Ong; Yuanyuan Cheng; Hannah V Siddle; A Bruce Lyons; Gregory M Woods; Andrew S Flies
Journal:  Open Biol       Date:  2022-10-19       Impact factor: 7.124

3.  Emerging Frontiers in the Study of Molecular Evolution.

Authors:  David A Liberles; Belinda Chang; Kerry Geiler-Samerotte; Aaron Goldman; Jody Hey; Betül Kaçar; Michelle Meyer; William Murphy; David Posada; Andrew Storfer
Journal:  J Mol Evol       Date:  2020-04       Impact factor: 2.395

4.  The immunopeptidomes of two transmissible cancers and their host have a common, dominant peptide motif.

Authors:  Annalisa Gastaldello; Sri H Ramarathinam; Alistair Bailey; Rachel Owen; Steven Turner; N Kontouli; Tim Elliott; Paul Skipp; Anthony W Purcell; Hannah V Siddle
Journal:  Immunology       Date:  2021-02-04       Impact factor: 7.397

5.  Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures.

Authors:  Pinar Uysal-Onganer; Stefania D'Alessio; Maria Mortoglou; Igor Kraev; Sigrun Lange
Journal:  Int J Mol Sci       Date:  2021-01-30       Impact factor: 5.923

6.  The differentiation state of the Schwann cell progenitor drives phenotypic variation between two contagious cancers.

Authors:  Rachel S Owen; Sri H Ramarathinam; Alistair Bailey; Annalisa Gastaldello; Kathryn Hussey; Paul J Skipp; Anthony W Purcell; Hannah V Siddle
Journal:  PLoS Pathog       Date:  2021-11-15       Impact factor: 6.823

Review 7.  A Devil of a Transmissible Cancer.

Authors:  Gregory M Woods; A Bruce Lyons; Silvana S Bettiol
Journal:  Trop Med Infect Dis       Date:  2020-04-01

8.  A novel system to map protein interactions reveals evolutionarily conserved immune evasion pathways on transmissible cancers.

Authors:  Andrew S Flies; Jocelyn M Darby; Patrick R Lennard; Peter R Murphy; Chrissie E B Ong; Terry L Pinfold; Alana De Luca; A Bruce Lyons; Gregory M Woods; Amanda L Patchett
Journal:  Sci Adv       Date:  2020-07-01       Impact factor: 14.136

9.  NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers.

Authors:  Chrissie E B Ong; Amanda L Patchett; Jocelyn M Darby; Jinying Chen; Guei-Sheung Liu; A Bruce Lyons; Gregory M Woods; Andrew S Flies
Journal:  J Cancer Res Clin Oncol       Date:  2021-04-02       Impact factor: 4.553

Review 10.  Challenges of an Emerging Disease: The Evolving Approach to Diagnosing Devil Facial Tumour Disease.

Authors:  Camila Espejo; Amanda L Patchett; Richard Wilson; A Bruce Lyons; Gregory M Woods
Journal:  Pathogens       Date:  2021-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.